Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
Trimetrexate-d9 is the deuterized labeled form of Trimetrexate (T798205), which is an FDA-approved drug which selectively inhibits Streptococcus mutans through targeting dihydrofolate reductase (DHFR).
400-821-0725
沪ICP备17019645号
